Evidence map›Paper›PMID 40964609›Full record

ReviewGates open research2025

WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever- key considerations and research gaps.

Ana Belen Ibarz Pavon, John Clemens, Alejandro Craviotto, John A Crump, Denise O Garrett, Melita A Gordon, Jacob John, Karen H Keddy, Matthew B Laurens, Xinxue Liu and 4 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Gates open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ana Belen Ibarz PavonWorld Health Organization. Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland.
John ClemensInternational Vaccine Institute, Seoul, South Korea.
Alejandro CraviottoUniversidad Autonoma de Mexico. Facultad de Medicina, Mexico City, Mexico.
John A CrumpUniversity of Otago. Centre for International Health., Dunedin, New Zealand.
Denise O GarrettSabin Vaccine Institute, Washington, District of Columbia, USA.
Melita A GordonUniversity of Liverpool. Department of Infection, Veterinary & Ecological Sciences, Liverpool, UK.
Jacob JohnChristian Medical College Vellore, Vellore, Tamil Nadu, India.
Karen H KeddyUniversity of Pretoria. Faculty of Veterinary Science. Department Veterinary Tropical Diseases, Pretoria, South Africa.
Matthew B LaurensUniversity of Maryland Center for Vaccine Development and Global Health, Baltimore, Maryland, USA.
Xinxue LiuUniversity of Oxford Oxford Vaccine Group, Oxford, England, UK.
Florian MarksInternational Vaccine Institute, Seoul, South Korea.
Andrew J PollardUniversity of Oxford Oxford Vaccine Group, Oxford, England, UK.
Senjuti SahaChild Health Research Foundation, Dhaka, Dhaka Division, Bangladesh.
Annelies Wilder-SmithWorld Health Organization. Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

In 2021,

Indexed as

Paratyphoid FeverSalmonella paratyphi ASalmonella typhiTyphoid FeverTyphoid-Paratyphoid VaccinesChild, PreschoolEvidence GapsHumansWorld Health OrganizationTyphoid-Paratyphoid Vaccinesparatyphoid feverSalmonella entericatyphoid fevervaccine

Identifiers

PMID40964609
PMCPMC12436677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.